Latest News and Press Releases

- 72 Acute Myeloid Leukemia and Lymphoma High-Risk Advanced Patients Enrolled: 94% Alive at Last Assessment Indicating Favorable Survival Benefit - - Long-Term Complete Remission and Significant Bone...

LOS ANGELES, May 04, 2023 (GLOBE NEWSWIRE) -- Captura, a carbon removal company founded at Caltech, and AltaSea at the Port of Los Angeles today announced a partnership that will further advance...

LONDON, May 04, 2023 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE:GSL) (the “Company”) has scheduled its Annual Meeting of Shareholders for June 6, 2023, at 10:00 a.m. Eastern Time (the “Annual...

World’s Brightest, Full-color OLED Microdisplay Using dPd™ Technology at 15,000 cd/m2 Tops Record Set by eMagin in 2021 HOPEWELL JUNCTION, N.Y., May 04, 2023 (GLOBE NEWSWIRE) -- eMagin...

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 04, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “The Company”), a leading provider of innovative technologies that...

NEWPORT BEACH, Calif. and SALT LAKE CITY, May 04, 2023 (GLOBE NEWSWIRE) -- Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), the leader in interactive video-based...

First fully-human multi-epitope binding broadly neutralizing immunoglobulin antibody therapeutic being developed for treatment of high-risk patients demonstrates safety and efficacy in Phase 1 and 2a...

Reached agreement with FDA on confirmatory Phase 3 clinical trial design in 408 subjects with primary endpoint of all-cause mortality at Day 60 Study to expand treatment population to include all...

VANCOUVER, British Columbia, May 04, 2023 (GLOBE NEWSWIRE) -- SPOD LITHIUM CORP. (“SPOD” or the “Company”) (CSE: SPOD) (OTCQB:SPODF) is pleased to announce that the Company’s Class A common shares,...

DALLAS , May 04, 2023 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) (“Triumph Financial” or the “Company”) announced today that it has completed its accelerated share repurchase...